Single use bioreactor control system
Effortlessly customize your control strategy for single-use bioprocesses, ensuring seamless integration and compatibility with your existing systems.

Controls and Optimizes Bioreactor Operations
The Single Use Bioreactor Control System offered by Marubishi Bioengineering is a customizable solution designed to seamlessly integrate into your biopharmaceutical production line, particularly when managing complex cell cultures and monoclonal antibody production. Its standout feature is the ability to tailor the control system according to your specific bioprocessing strategies, ensuring optimal performance and compliance with unique operational requirements.
This system excels in managing single-use bioreactors, commonly used in generating recombinant proteins and viral vectors intended for gene therapy. It supports continuous operations with an integrated SIP (Sterilization-In-Place) and CIP (Clean-In-Place) functionality to maintain sterility and operational efficiency.
Built for versatility, the system can manage various processing capacities, integrating smoothly with existing upstream and downstream processes. With a focus on energy efficiency, it incorporates advanced software for precise environment control, reducing energy consumption and system downtime.
Engineered from high-grade materials suitable for stringent biopharmaceutical conditions, it stands robust against potential corrosion, ensuring longevity and reliability. Certified to adhere to cGMP and FDA standards, this system is designed for the highest levels of compliance in the bioprocessing and life sciences industries.
For enhanced usability, it includes comprehensive support for system customization, remote monitoring, and flexible operational adjustments, ensuring it meets the varied demands of biotech and pharmaceutical applications.
Benefits
- Ensures seamless integration with existing bioprocess control strategies, reducing implementation time.
- Supports continuous operation, maximizing production efficiency and output quality.
- Reduces operational costs with energy-efficient motor control and advanced automation.
- Maintains compliance with cGMP and FDA standards for confidence in regulatory adherence.
- Enhances process adaptability with customizable system configurations tailored to specific production needs.
- Applications
- Biopharmaceuticals,Monoclonal antibodies (mabs),Bioprocess solutions,Cell cultures
- End products
- Cell therapy products,Personalized medicine formulations,Viral vectors for gene therapy,High-yield cell culture media,Biosimilars,Enzyme products,Recombinant proteins,Monoclonal antibody drugs
- Steps before
- Cell Culture Preparation,Inoculum Development,Media Preparation
- Steps after
- Protein Purification,Filtration,Formulation
- Input ingredients
- cells,biomass,media,feedstock
- Output ingredients
- bioproduct,concentrated cells,purified product,cell-free supernatant
- Market info
- Marubishi Bioengineering is known for its expertise in manufacturing high-quality bioreactors and fermentation systems for the biotechnology and pharmaceutical industries, reputed for their precision-engineering and customization to meet specific client requirements.
- Control system
- Customized for specific bioprocess
- Automation
- Automatic operation system for SIP and CIP
- Single use compatibility
- Bioreactor and downstream process
- Centrifuging system
- Continuous
- Membrane type
- Micro-filtration and ultrafiltration
- Control strategy
- Tailored to customer's specific needs
- SIP capability
- Yes
- CIP capability
- Yes
- Separation type
- Cell separation by micro-filtration
- Concentration type
- Product concentration by ultrafiltration
- Working mechanism
- Continuous centrifuging,membrane separation
- Integrated steps
- Micro-filtration and ultrafiltration
- CIP/SIP
- Automatic operation system for CIP/SIP
- Batch vs. continuous operation
- Continuous
- Automation level
- Customizable control system
- Cleaning method
- CIP / SIP
- Custom control strategy compatibility
- Customizable system integration
- Density/particle size
- 0.5–2.5 g/cm³ / 50–1000 µm
- Field of Application
- Monoclonal Antibodies
- Control panel type
- Customizable for user needs
- Compact footprint
- Yes
- Discharge method
- Automated
- Control system
- Customizable to suit specific control strategy
- HMI type
- Customizable based on user requirements
- Integration possibilities
- Automated valves,sensors,customized for SIP/CIP
- Control panel type
- Customizable based on bioprocess requirements
- Assembly unit
- Customizable with various units like centrifuging machine,piping systems